机构:[1]Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China首都医科大学宣武医院[2]China Int Neurosci Inst China INI, Beijing, Peoples R China[3]Liaocheng Brain Hosp, Dept Neurosurg, Liaocheng, Peoples R China[4]Capital Med Univ, Sch Publ Hlth, Beijing Key Lab Clin Epidemiol, Beijing, Peoples R China[5]Capital Med Univ, Xuanwu Hosp, Dept Lib, Beijing, Peoples R China首都医科大学宣武医院[6]Loma Linda Univ Hlth, Dept Neurol, Loma Linda, CA USA[7]Capital Med Univ, Xuanwu Hosp, Dept Radiol & Nucl Med, Beijing, Peoples R China首都医科大学宣武医院[8]Beijing Key Lab Magnet Resonance Imaging & Brain I, Beijing, Peoples R China[9]Harvard Med Sch, Massachusetts Gen Hosp, Neuroendovasc Program, Boston, MA USA[10]Fujian Med Univ, Zhangzhou Affiliated Hosp, Dept Neurol, Fuzhou, Peoples R China[11]Kunming Med Univ, Affiliated Hosp 2, Dept Cerebrovascular Dis, Kunming, Peoples R China[12]Capital Med Univ, Xuanwu Hosp, Dept Intervent Neuroradiol, Beijing, Peoples R China首都医科大学宣武医院
Background and purposeIn the landmark trials studying endovascular thrombectomy (EVT), pre-stroke dependent (PSD) patients were generally excluded. This systematic review and meta-analysis aimed to compare the safety and efficacy of EVT between PSD and pre-stroke independent (PSI) patients.MethodsWe searched CENTRAL, Embase, and Ovid MEDLINE up to 11 November 2021 for studies assessing PSD and PSI patients, which were separately defined as pre-stroke mRS score > 2 or > 1, and & LE;2 or & LE;1 accordingly. Two authors extracted data and assessed the risk of bias. A meta-analysis was carried out using the random-effects model. Adjusted OR and 95% CI were used to estimate adjusted pool effects. The main outcomes included favorable outcomes, successful recanalization, symptomatic intracranial hemorrhage, and 90-day mortality.ResultsA total of 8,004 records met the initial search strategy, and ten studies were included in the final decision. Compared with PSImRS & LE;2, PSDmRS > 2 had a lower favorable outcome (OR 0.51; 95% CI, 0.33-0.79) and higher 90-day mortality (OR 3.32; 95% CI, 2.77-3.98). No significant difference was found in successful recanalization and sICH. After adjustment, only 90-day mortality (aOR 1.99; 95% CI, 1.58-2.49) remained significantly higher in PSDmRS > 2. Compared with PSImRS & LE;1, PSDmRS > 1 had lower 90-day mortality (OR, 3.10; 95% CI, 1.84-5.24). No significant difference was found regarding the favorable outcome, successful recanalization, and sICH. After adjustment, no significant difference was found in a favorable outcome, but a higher rate of 90-day mortality (aOR, 2.13; 95% CI, 1.66-2.72) remained in PSDmRS > 1.ConclusionsPSD does not innately influence the EVT outcomes regarding sICH and favorable outcomes but may increase the risk of 90-day mortality. Until further evidence is available, it is reasonable to suggest EVT for patients with PSD.
第一作者机构:[1]Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China[2]China Int Neurosci Inst China INI, Beijing, Peoples R China
共同第一作者:
通讯作者:
通讯机构:[1]Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China[2]China Int Neurosci Inst China INI, Beijing, Peoples R China[12]Capital Med Univ, Xuanwu Hosp, Dept Intervent Neuroradiol, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Zhao Hengxiao,Bai Xuesong,Li Wei,et al.Influence of pre-stroke dependency on safety and efficacy of endovascular therapy: A systematic review and meta-analysis[J].FRONTIERS IN NEUROLOGY.2022,13:doi:10.3389/fneur.2022.956958.
APA:
Zhao, Hengxiao,Bai, Xuesong,Li, Wei,Tian, Qiuyue,Wang, Wenjiao...&Jiao, Liqun.(2022).Influence of pre-stroke dependency on safety and efficacy of endovascular therapy: A systematic review and meta-analysis.FRONTIERS IN NEUROLOGY,13,
MLA:
Zhao, Hengxiao,et al."Influence of pre-stroke dependency on safety and efficacy of endovascular therapy: A systematic review and meta-analysis".FRONTIERS IN NEUROLOGY 13.(2022)